The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,878.00
Bid: 1,868.00
Ask: 1,892.00
Change: 18.00 (0.97%)
Spread: 24.00 (1.285%)
Open: 1,828.00
High: 1,878.00
Low: 1,828.00
Prev. Close: 1,860.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Sep 2023 10:04

RNS Number : 6176M
Genus PLC
15 September 2023
 

15 September 2023

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 13 September 2023, conditional nil-cost share options were granted under the Genus 2019 Performance Share Plan ('PSP') over ordinary shares in Genus to the Executive Directors and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. This includes an option over shares worth 300% of salary for the Chief Executive Officer.

 

In accordance with the announcement of the proposed share awards for the incoming Chief Executive Officer on 2 May 2023, and as permitted under the Directors' Remuneration Policy approved by our shareholders in November 2022, an additional nil-cost share option was granted under the PSP to the Chief Executive Officer over ordinary shares worth 100% of salary, as listed in table B below. This option is conditional on shareholder approval at the forthcoming AGM, at which shareholders will also be asked to approve an amendment to the PSP rules to increase the limit on the value of shares over which an award can be granted in exceptional circumstances to 400% of salary, so as to align the exceptional circumstances limit under the PSP rules with that which shareholders have previously approved under the Directors' Remuneration Policy.

 

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2023 Annual Report which will be published next month.

 

In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ended 30 June 2023, nil-cost share options were granted over ordinary shares under the Genus 2019 Deferred Share Bonus Plan ('DSBP') as listed in table C below.

The price at which PSP and DSBP nil-cost share options have been granted was determined in accordance with the PSP and DSBP rules.

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail of the nil-cost option awards made on 13 September 2023.

 

For further information please contact:

 

Genus:

Cara Guedeney, Deputy Company Secretary Tel: +44 (0)1256 347100

 

Table A - GELT 2019 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Jorgen Kokke

2. Alison Henriksen

3. Matt Culbertson

4. Nate Zwald

5. Jerry Thompson

6. Elena Rice

7. Angelle Rosata

8. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Chief Executive Officer

2. Chief Financial Officer

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer

7. Group Human Resources Director

8. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the PSP over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 0p

93,032

2. 0p

45,157

3. 0p

25,817

4. 0p

21,972

5. 0p

21,972

6. 0p

22,615

7. 0p

20,489

8. 0p

21,450

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-09-13

f.

Place of the transaction

Outside a trading venue.

 

 

Table B - GELT 2019 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jorgen Kokke

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the PSP over ordinary shares in Genus, conditional on shareholder approval at the forthcoming AGM.

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

31,010

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2023-09-13

f.

Place of the transaction

Outside a trading venue.

 

 

Table C - GELT 2019 Deferred Share Bonus Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Alison Henriksen

3. Matt Culbertson

4. Nate Zwald

5. Jerry Thompson

6. Elena Rice

7. Angelle Rosata

8. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Executive Director

2. Chief Financial Officer

3. Chief Operating Officer Genus PIC

4. Chief Operating Officer Genus ABS Dairy

5. Chief Operating Officer Genus ABS Beef

6. Chief Scientific Officer

7. Group Human Resources Director

8. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the DSBP following the compulsory deferral of 33% and 25% of annual bonus for Executive Directors and members of GELT respectively in respect of bonuses earned in the financial year ended 30 June 2023.

 

c.

Price(s) and volume(s)

Numbers 1 to 8 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 0p

3,826

2. 0p

2,336

3. 0p

1,772

4. 0p

859

5. 0p

859

6. 0p

1,459

7. 0p

1,237

8. 0p

1,450

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

e.

Date of the transaction

2023-09-13

 

f.

Place of the transaction

Outside a trading venue.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUVRKROOUKARR
Date   Source Headline
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.